PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis

NHS Trust

Status: Completed

Conditions: COVID; Inflammatory Bowel Diseases

Study type: Observational

Funder types: Other

Identifiers

NCT04411784

284030

Details and patient eligibility

About

Whether the perceived changes in management of Acute Severe Ulcerative Colitis during the COVID pandemic are widespread, and whether they have any impact on patient outcomes

Full description

The study aims to evaluate the process, evaluation and therapy variation in management of ASUC with reference to 2019 British Society of Gastroenterology guidelines and see whether there are any differences between ambulatory and hospital management in ASUC. Also to evaluate the outcomes in ASUC patients managed during the COVID-19 pandemic

Enrollment: 10 patients

Sex: All

Ages: 16 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 16 -100 inclusive
• Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

Exclusion criteria

• Patients aged 16 -100 inclusive

• Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

  • Admission for elective colectomy
  • Pouch or stoma

Trial design

10 participants in 2 patient groups

Main group

Description:

Patient with Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

Control Group

Description:

Patients with ASUC managed in the unit from 1st Jan to 31st June 2019